(Reuters) – Global spending on medicines will reach $1.4 trillion in 2020, driven by increased healthcare access in emerging markets and high-priced new drugs for cancer and other diseases, according to a forecast by IMS Health released on Wednesday.
That is up from about $1.07 trillion this year, representing a compound annual growth rate of 4 to 7 percent over the next five years, the “Global Medicines Use in 2020” report compiled by IMS Institute for Healthcare Informatics found.
Some 225 new drugs will come to market over the next five years, about a third aimed at cancer, as well as medicines for rare diseases, which can carry ultra-high price tags, and treatments for autoimmune diseases and heart disease, the report said.
By 2020, 4.5 trillion doses of medicine will be dispensed, up 24 percent from 2015, with the average cost just 30 cents a dose, IMS estimated. Over half of the world’s population will consume at least one medicine per person per day, up from one third of the world in 2005, growth led by India, China, Brazil and Indonesia, the report predicted.
Why not use a common sense approach to your health and financial well being!
by shifting that mindset and buying power you will improve your health and solve your financial situations all at the same time. Instead of just buying high priced medications and helping the pharmaceutical companies fatten their pockets why not help yourselves and others to become free from that system..